Table 5.
Independent variable | Odds ratio | 95% confidence interval | P-value |
---|---|---|---|
Patient-related | |||
Age | 1·000 | 0·981–1·021 | 0·961 |
Gender | 1·677 | 0·892–3·150 | 0·108 |
Disease-related | |||
Duration of disease before treatment | 1·000 | 0·995–1·011 | 0·440 |
Severity of disease before treatment | 0·883 | 0·364–2·144 | 0·783 |
Number of affected orofacial sites | 1·060 | 0·634–1·772 | 0·823 |
Presence or absence of facial (nonlabial) swelling | 1·098 | 0·386–3·121 | 0·861 |
Treatment-related | |||
Total dose of triamcinolone | 1·002 | 0·996–1·008 | 0·441 |
Total number of courses of therapy | 1·573 | 0·946–2·614 | 0·081 |
Observation period after first course of treatment | 1·010 | 0·985–1·036 | 0·450 |